BioCorRx Inc.

2390 East Orangewood Avenue

Suite 575

Anaheim, California 92086

 

September 7, 2018

 

VIA EDGAR

 

U.S. Securities & Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

 

Re:

BioCorRx Inc.

 

Registration Statement on Form S-1

 

File No. 333-227009

 

Ladies and Gentlemen:

 

In accordance with Rule 461 of the Securities Act of 1933, as amended, BioCorRx Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern Time on Wednesday, September 12, 2018, or as soon thereafter as possible.

 

* * * *

 

Very Truly Yours,

 

BioCorRx Inc.

 

/s/ Brady Granier

 

Brady Granier

 

President and Chief Executive Officer